Summary Immuno-Biological Laboratories Co Ltd (IBL) is a pharmaceutical company that develops, manufactures and markets diagnostic products. The company's business areas include diagnostic and research reagents, customized services, global sales network, protein production business using transgenic silkworms, testing and cosmetic business. Its products include antibodies, EIA kits, and proteins. IBL provides antibody for cancer research, cytokines and other research. The company offers EIA kits for Alzheimer's disease, inflammation and cancer, cytokines, and metabolism and endocrine related diseases. Its medicines and in-vitro diagnostic products are used for promoting the fight against disease and to assist human welfare. IBL is headquartered in Fujioka, Japan. Immuno-Biological Laboratories Co Ltd (4570) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and... Research Beam Model: Research Beam Product ID: 1951561 250 USD New
Immuno-Biological Laboratories Co Ltd (4570) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Immuno-Biological Laboratories Co Ltd (4570) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : August   2017
  • Pages : 20
  • Publisher : GlobalData
 
 
 
Summary

Immuno-Biological Laboratories Co Ltd (IBL) is a pharmaceutical company that develops, manufactures and markets diagnostic products. The company's business areas include diagnostic and research reagents, customized services, global sales network, protein production business using transgenic silkworms, testing and cosmetic business. Its products include antibodies, EIA kits, and proteins. IBL provides antibody for cancer research, cytokines and other research. The company offers EIA kits for Alzheimer's disease, inflammation and cancer, cytokines, and metabolism and endocrine related diseases. Its medicines and in-vitro diagnostic products are used for promoting the fight against disease and to assist human welfare. IBL is headquartered in Fujioka, Japan.

Immuno-Biological Laboratories Co Ltd (4570) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Immuno-Biological Laboratories Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Immuno-Biological Laboratories Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Immuno-Biological Laboratories Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Immuno-Biological Laboratories Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Immuno-Biological Laboratories Co Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Immuno-Biological Laboratories Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Immuno-Biological Laboratories Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
TransGenic Enters into Research Agreement with Immuno-Biological Labs 11
Equity Offering 12
Immuno-Biological Labs Raises USD11 Million in Private Placement of Shares upon Exercise of Warrants 12
Immuno-Biological Labs Raises USD1.8 Million in Private Placement of Shares 13
Debt Offering 14
Immuno-Biological Labs Raises USD12.3 Million in Public Offering of Bonds 14
Immuno-Biological Labs Raises USD1.7 Million in Private Placement of Bonds 15
Acquisition 16
Immuno-Biological Labs To Acquire Additional 58.2% Stake In Japan Based Company For US$0.8 Million 16
Immuno-Biological Laboratories Co Ltd - Key Competitors 17
Immuno-Biological Laboratories Co Ltd - Key Employees 18
Immuno-Biological Laboratories Co Ltd - Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Immuno-Biological Laboratories Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Immuno-Biological Laboratories Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Immuno-Biological Laboratories Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Immuno-Biological Laboratories Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Immuno-Biological Laboratories Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Immuno-Biological Laboratories Co Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Immuno-Biological Laboratories Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
TransGenic Enters into Research Agreement with Immuno-Biological Labs 11
Immuno-Biological Labs Raises USD11 Million in Private Placement of Shares upon Exercise of Warrants 12
Immuno-Biological Labs Raises USD1.8 Million in Private Placement of Shares 13
Immuno-Biological Labs Raises USD12.3 Million in Public Offering of Bonds 14
Immuno-Biological Labs Raises USD1.7 Million in Private Placement of Bonds 15
Immuno-Biological Labs To Acquire Additional 58.2% Stake In Japan Based Company For US$0.8 Million 16
Immuno-Biological Laboratories Co Ltd, Key Competitors 17
Immuno-Biological Laboratories Co Ltd, Key Employees 18
Immuno-Biological Laboratories Co Ltd, Other Locations 19
Immuno-Biological Laboratories Co Ltd, Subsidiaries 19
List of Figures
Immuno-Biological Laboratories Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Immuno-Biological Laboratories Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Immuno-Biological Laboratories Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Immuno-Biological Laboratories Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Immuno-Biological Laboratories Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Immuno-Biological Laboratories Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Immuno-Biological Laboratories Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Immuno-Biological Laboratories Co Ltd, Medical Devices Deals, 2011 to YTD 2017 9
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter